BLIMP-1 and STAT3 counterregulate microRNA-21 during plasma cell differentiation

Journal of Immunology

Volumn 189, Issue 1, 2012, Pages 253-260

  Barnes, Nicholas A ^a   Stephenson, Sophie ^a   Cocco, Mario ^a   Tooze, Reuben M ^a   Doody, Gina M ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; MESSENGER RNA; MICRORNA 21; STAT3 PROTEIN;

ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PLASMA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA TRANSCRIPTION; UPREGULATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; DOWN-REGULATION; FEEDBACK, PHYSIOLOGICAL; HELA CELLS; HEP G2 CELLS; HUMANS; L CELLS (CELL LINE); MICE; MICRORNAS; PLASMA CELLS; REPRESSOR PROTEINS; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR;

EID: 84862889421     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101563     Document Type: Article

References (47)

1. Shapiro-Shelef, M., K. I. Lin, L. J. McHeyzer-Williams, J. Liao, M. G. McHeyzer-Williams, and K. Calame. 2003. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity 19: 607-620. (Pubitemid 37311441)
2. Zotos, D., J. M. Coquet, Y. Zhang, A. Light, K. D'Costa, A. Kallies, L. M. Corcoran, D. I. Godfrey, K. M. Toellner, M. J. Smyth, et al. 2010. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J. Exp. Med. 207: 365-378.
3. Linterman, M. A., L. Beaton, D. Yu, R. R. Ramiscal, M. Srivastava, J. J. Hogan, N. K. Verma, M. J. Smyth, R. J. Rigby, and C. G. Vinuesa. 2010. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J. Exp. Med. 207: 353-363.
4. Kwon, H., D. Thierry-Mieg, J. Thierry-Mieg, H. P. Kim, J. Oh, C. Tunyaplin, S. Carotta, C. E. Donovan, M. L. Goldman, P. Tailor, et al. 2009. Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity 31: 941-952.
5. Diehl, S. A., H. Schmidlin, M. Nagasawa, S. D. van Haren, M. J. Kwakkenbos, E. Yasuda, T. Beaumont, F. A. Scheeren, and H. Spits. 2008. STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. J. Immunol. 180: 4805-4815.
6. Fornek, J. L., L. T. Tygrett, T. J. Waldschmidt, V. Poli, R. C. Rickert, and G. S. Kansas. 2006. Critical role for Stat3 in T-dependent terminal differentiation of IgG B cells. Blood 107: 1085-1091. (Pubitemid 43156309)
7. Iliopoulos, D., S. A. Jaeger, H. A. Hirsch, M. L. Bulyk, and K. Struhl. 2010. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol. Cell 39: 493-506.
8. Calin, G. A., and C. M. Croce. 2006. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6: 857-866. (Pubitemid 44629897)
9. Malumbres, R., K. A. Sarosiek, E. Cubedo, J.W. Ruiz, X. Jiang, R. D. Gascoyne, R. Tibshirani, and I. S. Lossos. 2009. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 113: 3754-3764.
10. Roehle, A., K. P. Hoefig, D. Repsilber, C. Thorns, M. Ziepert, K. O. Wesche, M. Thiere, M. Loeffler, W. Klapper, M. Pfreundschuh, et al. 2008. MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. Br. J. Haematol. 142: 732-744.
11. Lawrie, C. H., S. Soneji, T. Marafioti, C. D. Cooper, S. Palazzo, J. C. Paterson, H. Cattan, T. Enver, R. Mager, J. Boultwood, et al. 2007. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int. J. Cancer 121: 1156-1161. (Pubitemid 47101656)
12. Pichiorri, F., S. S. Suh, M. Ladetto, M. Kuehl, T. Palumbo, D. Drandi, C. Taccioli, N. Zanesi, H. Alder, J. P. Hagan, et al. 2008. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc. Natl. Acad. Sci. USA 105: 12885-12890.
13. Löffler, D., K. Brocke-Heidrich, G. Pfeifer, C. Stocsits, J. Hackermüller, A. K. Kretzschmar, R. Burger, M. Gramatzki, C. Blumert, K. Bauer, et al. 2007. Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110: 1330-1333. (Pubitemid 47281433)
14. Hoefig, K. P., C. Thorns, A. Roehle, C. Kaehler, K. O. Wesche, D. Repsilber, B. Branke, M. Thiere, A. C. Feller, and H. Merz. 2008. Unlocking pathology archives for microRNA-profiling. Anticancer Res. 28(1A): 119-123.
15. Martins, G., and K. Calame. 2008. Regulation and functions of Blimp-1 in T and B lymphocytes. Annu. Rev. Immunol. 26: 133-169. (Pubitemid 351600373)
16. Pasqualucci, L., M. Compagno, J. Houldsworth, S. Monti, A. Grunn, S. V. Nandula, J. C. Aster, V. V. Murty, M. A. Shipp, and R. Dalla-Favera. 2006. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. J. Exp. Med. 203: 311-317. (Pubitemid 43290840)
17. Tam, W., M. Gomez, A. Chadburn, J. W. Lee, W. C. Chan, and D. M. Knowles. 2006. Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas. Blood 107: 4090-4100. (Pubitemid 43726818)
18. Lam, L. T., G. Wright, R. E. Davis, G. Lenz, P. Farinha, L. Dang, J. W. Chan, A. Rosenwald, R. D. Gascoyne, and L. M. Staudt. 2008. Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factorkappaB pathways in subtypes of diffuse large B-cell lymphoma. Blood 111: 3701-3713.
19. Alon, U. 2007. Network motifs: theory and experimental approaches. Nat. Rev. Genet. 8: 450-461. (Pubitemid 46789247)
20. Arpin, C., J. Déchanet, C. Van Kooten, P. Merville, G. Grouard, F. Brière, J. Banchereau, and Y. J. Liu. 1995. Generation of memory B cells and plasma cells in vitro. Science 268: 720-722.
21. Doody, G. M., S. Stephenson, and R. M. Tooze. 2006. BLIMP-1 is a target of cellular stress and downstream of the unfolded protein response. Eur. J. Immunol. 36: 1572-1582. (Pubitemid 43942145)
22. Tooze, R. M., S. Stephenson, and G. M. Doody. 2006. Repression of IFN-gamma induction of class II transactivator: a role for PRDM1/Blimp-1 in regulation of cytokine signaling. J. Immunol. 177: 4584-4593. (Pubitemid 44469790)
23. Doody, G. M., S. Stephenson, C. McManamy, and R. M. Tooze. 2007. PRDM1/ BLIMP-1 modulates IFN-gamma-dependent control of the MHC class I antigen-processing and peptide-loading pathway. J. Immunol. 179: 7614-7623.
24. Bert, A. G., J. Burrows, C. S. Osborne, and P. N. Cockerill. 2000. Generation of an improved luciferase reporter gene plasmid that employs a novel mechanism for high-copy replication. Plasmid 44: 173-182.
25. Asangani, I. A., S. A. Rasheed, D. A. Nikolova, J. H. Leupold, N. H. Colburn, S. Post, and H. Allgayer. 2008. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136. (Pubitemid 351485639)
26. Schmidlin, H., S. A. Diehl, M. Nagasawa, F. A. Scheeren, R. Schotte, C. H. Uittenbogaart, H. Spits, and B. Blom. 2008. Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression. Blood 112: 1804-1812.
27. Ettinger, R., G. P. Sims, A. M. Fairhurst, R. Robbins, Y. S. da Silva, R. Spolski, W. J. Leonard, and P. E. Lipsky. 2005. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J. Immunol. 175: 7867-7879. (Pubitemid 41798347)
28. Bryant, V. L., C. S. Ma, D. T. Avery, Y. Li, K. L. Good, L. M. Corcoran, R. de Waal Malefyt, and S. G. Tangye. 2007. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J. Immunol. 179: 8180-8190.
29. Good, K. L., V. L. Bryant, and S. G. Tangye. 2006. Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21. J. Immunol. 177: 5236-5247. (Pubitemid 44527596)
30. Ettinger, R., G. P. Sims, R. Robbins, D. Withers, R. T. Fischer, A. C. Grammer, S. Kuchen, and P. E. Lipsky. 2007. IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells. J. Immunol. 178: 2872-2882. (Pubitemid 46333165)
31. Avery, D. T., V. L. Bryant, C. S. Ma, R. de Waal Malefyt, and S. G. Tangye. 2008. IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4. J. Immunol. 181: 1767-1779.
32. Konforte, D., and C. J. Paige. 2006. Identification of cellular intermediates and molecular pathways induced by IL-21 in human B cells. J. Immunol. 177: 8381- 8392.
33. Zeng, R., R. Spolski, E. Casas, W. Zhu, D. E. Levy, and W. J. Leonard. 2007. The molecular basis of IL-21-mediated proliferation. Blood 109: 4135-4142. (Pubitemid 46743374)
34. Reljic, R., S. D. Wagner, L. J. Peakman, and D. T. Fearon. 2000. Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6. J. Exp. Med. 192: 1841-1848.
35. van der Fits, L., M. S. van Kester, Y. Qin, J. J. Out-Luiting, F. Smit, W. H. Zoutman, R. Willemze, C. P. Tensen, and M. H. Vermeer. 2011. MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sézary syndrome. J. Invest. Dermatol. 131: 762-768.
36. Fujita, S., T. Ito, T. Mizutani, S. Minoguchi, N. Yamamichi, K. Sakurai, and H. Iba. 2008. miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J. Mol. Biol. 378: 492-504.
37. Cai, X., C. H. Hagedorn, and B. R. Cullen. 2004. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10: 1957-1966. (Pubitemid 39557833)
38. Doody, G. M., M. A. Care, N. J. Burgoyne, J. R. Bradford, M. Bota, C. Bonifer, D. R. Westhead, and R. M. Tooze. 2010. An extended set of PRDM1/BLIMP1 target genes links binding motif type to dynamic repression. Nucleic Acids Res. 38: 5336-5350.
39. Patrick, D. M., R. L. Montgomery, X. Qi, S. Obad, S. Kauppinen, J. A. Hill, E. van Rooij, and E. N. Olson. 2010. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J. Clin. Invest. 120: 3912-3916.
40. Chau, B. N., C. Xin, J. Hartner, S. Ren, A. P. Castano, G. Linn, J. Li, P. T. Tran, V. Kaimal, X. Huang, et al. 2012. MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci. Transl. Med. 4: 121ra18.
41. Oracki, S. A., J. A. Walker, M. L. Hibbs, L. M. Corcoran, and D. M. Tarlinton. 2010. Plasma cell development and survival. Immunol. Rev. 237: 140-159.
42. Hatley, M. E., D. M. Patrick, M. R. Garcia, J. A. Richardson, R. Bassel-Duby, E. van Rooij, and E. N. Olson. 2010. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18: 282-293.
43. Liu, M., H. Wu, T. Liu, Y. Li, F. Wang, H. Wan, X. Li, and H. Tang. 2009. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell Res. 19: 828-837.
44. Connolly, E. C., K. Van Doorslaer, L. E. Rogler, and C. E. Rogler. 2010. Overexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor RHOB. Mol. Cancer Res. 8: 691-700.
45. Volinia, S., G. A. Calin, C. G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, et al. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103: 2257-2261. (Pubitemid 43271657)
46. Krichevsky, A. M., and G. Gabriely. 2009. miR-21: a small multi-faceted RNA. J. Cell. Mol. Med. 13: 39-53.
47. Gibcus, J. H., L. P. Tan, G. Harms, R. N. Schakel, D. de Jong, T. Blokzijl, P. Möller, S. Poppema, B. J. Kroesen, and A. van den Berg. 2009. Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. Neoplasia 11: 167-176.